Fund Information / Factsheet • Apr 26, 2023
Fund Information / Factsheet
Open in ViewerOpens in native device viewer



Performance over (%) 6m 1y 3y 5y 10y Share price (Total return) 12.7 4.5 48.4 30.2 86.0 NAV (Total return) 12.1 4.1 52.2 31.3 86.0 Benchmark (Total return) 12.3 2.9 47.4 27.8 75.9 Relative NAV (Total return) -0.1 1.2 4.8 3.4 10.1
| Discrete year performance (%) |
Share price (total return) |
NAV (total return) |
|---|---|---|
| 31/3/2022 to 31/3/2023 |
4.5 | 4.1 |
| 31/3/2021 to 31/3/2022 |
15.0 | 16.3 |
| 31/3/2020 to 31/3/2021 |
23.4 | 25.7 |
| 31/3/2019 to 31/3/2020 |
-17.8 | -19.8 |
| 31/3/2018 to 31/3/2019 |
6.7 | 7.6 |
n/a n/a n/a All performance, cumulative growth and annual growth data is sourced from Morningstar.
Source: at 31/03/23. © 2023 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not predict future returns.
The Company underperformed the FTSE All-Share Index during the month.
The Company produced a negative net asset value total return of 2.9%, underperforming the FTSE All-Share's negative total return of 2.8%. The biggest detractors were AstraZeneca (an underweight position), followed by IG and Phoenix. The biggest positive contributors were BAE Systems, followed by Shell and HSBC (both underweight positions).
UK equities continue to be on the receiving end of takeover bids from overseas companies and private equity firms, which is an indicator of the value on offer. The dividend yield of UK equities remains attractive to us relative to the main alternatives.
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.
The Company's objective is to provide long-term growth in income and capital, principally by investment in equities listed on the London Stock Exchange. The Board fully recognises the importance of dividend income to shareholders.
Renowned for its record-setting annual dividend increases since 1966, the Company targets longterm income and capital growth.
| NAV (cum income) | 404.8p | |||
|---|---|---|---|---|
| NAV (ex income) | 400.6p | |||
| Share price | 414.0p | |||
| Discount(-)/premium(+) | 2.3% | |||
| Yield | 4.8% | |||
| Net gearing | 7% | |||
| Net cash | - | |||
| Total assets Net assets |
£2,112m £1,985m |
|||
| Market capitalisation | £2,030m | |||
| Total voting rights | 490,279,868 | |||
| Total number of holdings | 88 | |||
| Ongoing charges (year end 30 June 2022) |
0.37% | |||
| Overall Morningstar RatingTM |
| |||
| Benchmark | FTSE All-Share Index | |||
| Source: BNP Paribas for holdings information and Morningstar for all |
Source: BNP Paribas for holdings information and Morningstar for all other data. Differences in calculation may occur due to the methodology used.
Please note that the total voting rights in the Company do not include shares held in Treasury.
Please note that this chart could include dividends that have been declared but not yet paid.
Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested. Please refer to glossary for definition of share price total return.
How to invest Go to www.janushenderson.com/howtoinvest Find out more Go to www.cityinvestmenttrust.com
| Top 10 holdings | (%) |
|---|---|
| Shell | 3.7 |
| BAE Systems | 3.6 |
| British American Tobacco | 3.5 |
| Diageo | 3.4 |
| RELX | 3.2 |
| BP | 3.1 |
| Unilever | 3.0 |
| AstraZeneca | 2.9 |
| HSBC | 2.8 |
| Imperial Brands | 2.6 |

Consumer Basic Consumer Telecommuni
Sector breakdown (%)
References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.




calculated using mid-market share price with dividends reinvested.

All performance, cumulative growth and annual growth data is sourced from Morningstar. Share price total return is

| The above sector breakdown may not add up to 100% due to rounding. | ||
|---|---|---|
| Stock code | CTY | ||
|---|---|---|---|
| AIC sector | AIC UK Equity Income | ||
| Benchmark | FTSE All-Share Index | ||
| Company type | Conventional (Ords) | ||
| Launch date | 1891 | ||
| Financial year | 30-Jun | ||
| Dividend payment | November, February, May, August |
||
| Risk rating (Source: Numis) |
Average | ||
| Management fee | 0.325% per annum of net assets |
||
| Performance fee | No | ||
| (See Annual Report & Key Information Document for more information) | |||
| Regional focus | UK | ||
| Fund manager appointment |
Job Curtis 1991 David Smith 2021 |



Please remember that past performance does not predict future returns. The value of an investment and the income from it can rise as well as fall as a result of market and currency fluctuations, and you may not get back the amount originally invested.
How to invest Go to www.janushenderson.com/howtoinvest Customer services 0800 832 832
Equities sold off in the first half of the month after the collapse of two US regional banks and concerns about Credit Suisse, which was subsequently taken over by Swiss rival UBS. This helped to ease some concerns about financial contagion and spurred a rebound in equities towards the end of the month. Overall, UK equities, as measured by the FTSE All-Share Index, fell 2.8%. The UK's annual inflation rate rose to 10.4% in February, from 10.1% in January and compared with market expectations for a slowdown to 9.9%. The Bank of England raised its base rate by 25 basis points to 4.25%.
The Company produced a negative net asset value total return of 2.9%, underperforming the FTSE All-Share's negative total return of 2.8%.
The biggest stock detractor was AstraZeneca, the pharmaceutical company, where the Company has an underweight position relative to the FTSE All-Share Index. The holdings in IG, the online trading company, and Phoenix, the life assurer, were also notable detractors, despite their above average dividend yields. The biggest positive stock contributor was BAE Systems, the defence contractor, followed by being underweight in Shell, the oil company, and HSBC.
Against a backdrop of general weakness in the financial sector, we made additions to various holdings which we thought offered attractive dividend yields and where we liked the medium-term outlook. These included two banks, HSBC and Lloyds, life assurance firms, Legal & General and Phoenix, financial services companies, M&G and Schroders, as well as real estate investment trust, Land Securities. On the other hand, we reduced the position in Direct Line Insurance, which is not currently paying a dividend.
The rate of UK inflation could fall as the rise in the oil price at the start of the Ukraine war drops out of the 12-month calculation. Although interest rates are seemingly near to their peak, they are unlikely to decline soon in our view, given the strength of the labour market and continuing upward pressure on wages. We also believe the UK economy could narrowly avoid recession, while the reopening of the Chinese economy is a boost to global growth. UK equities continue to be on the receiving end of takeover bids from overseas companies and private equity firms, which is an indicator of the value on offer. The dividend yield of UK equities remains attractive to us relative to the main alternatives.

The amount by which the price per share of an investment company is either lower (at a discount) or higher (at a premium) than the net asset value per share (cum income), expressed as a percentage of the net asset value per share.
The effect of borrowing money for investment purposes (financial gearing). The amount a company can "gear" is the amount it can borrow in order to invest. Gearing is used in the expectation that the returns on the investments bought will exceed the costs of the borrowings that funded the purchase. This Company can also use synthetic gearing through derivatives and foreign exchange hedging and/or other non-fully funded instruments or techniques.
The Company's leverage is the sum of financial gearing and synthetic gearing. Details of the Company's leverage limits can be found in both the Key Information Document and Annual Report. Where a company utilises leverage, the profits and losses incurred by the company can be greater than those of a company that does not use leverage.
Month end closing mid-market share price multiplied by the number of shares outstanding at month end.
The total value of a fund's assets less its liabilities.
The value of investments and cash, including current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The value of investments and cash, excluding current year revenue, less liabilities (prior charges such as loans, debenture stock and preference shares at fair value).
The theoretical total return on shareholders' funds per share reflecting the change in Net Asset Value (NAV) assuming that dividends paid to shareholders were reinvested at NAV at the time the shares were quoted ex-dividend. A way of measuring investment management performance of investment trusts which is not affected by movements in discounts/premiums.
Total assets minus any liabilities such as bank loans or creditors.
A company's net exposure to cash/cash equivalents expressed as a percentage of shareholders' funds, after any offset against its gearing. This is only shown for companies that have gearing in place.
A company's total assets (less cash/cash equivalents) divided by shareholders' funds expressed as a percentage.
The total expenses for the financial year (excluding performance fee), divided by the average daily net assets, multiplied by 100.
The key measure used to assess risk is volatility of returns, using historic net asset value (NAV) performance of the company over 1 and 3 years. In this instance volatility measures how much a company's NAV fluctuates over time in relation to the UK Equity market. The higher a volatility figure, the more the NAV has fluctuated (both up and down) over time. Please note that risk categorisations are indicative and based principally on historic data and should not be solely relied upon when making investment decisions.
Closing mid-market share price at month end.
The theoretical total return to the investor assuming that all dividends received were reinvested in the shares of the company at the time the shares were quoted ex-dividend. Transaction costs are not taken into account.
Cum Income NAV multiplied by the number of shares, plus prior charges at fair value.
Calculated by dividing the current financial year's dividends per share (this will include prospective dividends) by the current price per share, then multiplying by 100 to arrive at a percentage figure.
For a full list of terms please visit:
https://www.janushenderson.com/en-gb/investor/glossary/

Overall Morningstar Rating™ is a measure of a fund's risk-adjusted return, relative to similar funds. Fund share classes are rated from 1 to 5 stars, with the best performers receiving 5 stars and the worst performers receiving a single star. Overall Morningstar Rating™ is shown for an investment company achieving a rating of 4 or 5.
Morningstar Analyst Rating™
Ratings should not be taken as a recommendation. For more detailed information about Morningstar Ratings, including its methodology, please go to global.morningstar.com/managerdisclosures.
Not for onward distribution. Before investing in an investment trust referred to in this document, you should satisfy yourself as to its suitability and the risks involved, you may wish to consult a financial adviser. This is a marketing communication. Please refer to the AIFMD Disclosure document and Annual Report of the AIF before making any final investment decisions. Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested. Tax assumptions and reliefs depend upon an investor's particular circumstances and may change if those circumstances or the law change. Nothing in this document is intended to or should be construed as advice. This document is not a recommendation to sell or purchase any investment. It does not form part of any contract for the sale or purchase of any investment. We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.
Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), Henderson Equity Partners Limited (reg. no.2606646), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 2 Rue de Bitbourg, L-1273, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).
Janus Henderson, Knowledge Shared and Knowledge Labs are trademarks of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.